SCHEMBL735199

SCHEMBL735199

CCCCC1(N2CCCC2)CC=C(c2[nH]c3ccccc3c2CCc2ccncc2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.36
HTR2A P28223 5/20 0.34
HTR2C P28335 4/20 0.34
DRD2 P14416 3/20 0.33
DRD3 P35462 1/20 0.33
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
TSHR P16473 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
MAPT P10636 1/20 0.32
CRHBP P24387 1/20 0.32
MAPK1 P28482 1/20 0.32
CRHR2 Q13324 1/20 0.32
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL735439 0.82 OPRM1 (0.37) TSHRMEN1KMT2AMAPTCRHBP
SCHEMBL2197876 0.82 MAPT (0.36) SIGMAR1DRD3TSHRMEN1KMT2A
SCHEMBL733673 0.82 FNTA (0.36) SIGMAR1HTR2AHTR2CDRD2FNTA
SCHEMBL734189 0.80 FNTA (0.33) HTR2AHTR2CDRD2DRD3FNTA
SCHEMBL736107 0.79 SIGMAR1 (0.38) SIGMAR1HTR2AHTR2CDRD2DRD3
SCHEMBL734725 0.74 OPRM1 (0.41) HTR2AHTR2CFNTAFNTB
SCHEMBL733852 0.73 OPRM1 (0.41) HTR2AHTR2CFNTAFNTB
SCHEMBL734247 0.73 OPRM1 (0.38) SIGMAR1HTR2AHTR2CDRD2FNTA
SCHEMBL734569 0.71 HTR2A (0.38) SIGMAR1HTR2AHTR2CDRD2FNTA
SCHEMBL735257 0.70 OPRM1 (0.43) SIGMAR1HTR2AHTR2CDRD2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP claimed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US claimed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US claimed
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 SIGMAR1 873/4885HTR2A 238/4885HTR2C 118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.